Page results
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH Pain Management Centre is a nationally recognized centre of excellence for people with longstanding pain.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH will play a vital role in a new respiratory virus study.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Trial of T-cell therapy for lung cancer begins at UCLH
File results
-
FOI/2024/0132 - Cancer patients diagnosed in A&E
-
FOI/2024/0133 - Non-Emergency Patient Transport Services (NEPTS)
-
FOI/2024/0134 - Joint infection services for paediatric/ adult patients
-
FOI/2024/0136 - Female Genital Mutilation (FGM) cases from 2014-February 2024
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0143 - Individuals arriving at A&E not in an ambulance
-
FOI/2024/0144 - Breast cancer treatment
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer